Salix contacts Actavis over potential sale-source

Wed Sep 24, 2014 9:24am EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

NEW YORK, Sept 24 (Reuters) - Salix Pharmaceuticals Ltd has had contact with Actavis Plc about a potential sale to the larger drugmaker, as it continues discussions with Allergan Inc about selling itself, according to a person familiar with the matter.

Allergan has revived discussions to buy Salix in recent weeks after on-and-off talks for nearly a year, as it tries to fend off a hostile offer from Valeant Pharmaceuticals Inc , Reuters reported earlier this week.

CNBC reported earlier Wednesday that Salix was in early-stage discussions with Actavis.

Representatives for Salix and Actavis could not be immediately reached for comment. (Reporting by Olivia Oran in New York; Editing by Bernadette Baum)